The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide
2019 ◽
Vol 54
(7)
◽
pp. 1164-1167
◽
Keyword(s):
T Cell
◽
2020 ◽
Vol 20
◽
pp. S201-S202
2011 ◽
Vol 17
(2)
◽
pp. S230
2020 ◽
Vol Publish Ahead of Print
◽
2017 ◽
Vol 23
(3)
◽
pp. S200-S201
◽
2020 ◽
Vol 26
(3)
◽
pp. S181
2014 ◽
Vol 20
(2)
◽
pp. S262